| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |